Sanjay Munireddy, MD
Surgical Oncology · Albany, GANPI 1255476107
Payments from drug & device makers
What this record shows
The money is spread across several categories — travel and lodging (56.6%), food and beverage and entertainment — rather than concentrated in one kind of arrangement. 25 manufacturers reported payments, led by Stryker at 54.1% of the total. Reporting peaked in 2022 at $1,400 and has fallen 51.5% since, to $679 in 2025.
Across 65 payments — averaging $68.91 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Stryker$2K
- Intuitive Surgical$646
- Merck$176
- Hitachi Healthcare Americas Corp.$166
- AstraZeneca$158
- Regeneron Healthcare Solutions, Inc.$146
- plus $763 from 19 others
What the payments were for
- Travel & lodging$2,53657%
- Food & beverage$1,76139%
- Education$160%
- Entertainment$1664%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Stryker | 15 | $2,424 |
| Intuitive Surgical | 7 | $646 |
| Merck | 7 | $176 |
| Hitachi Healthcare Americas Corp. | 1 | $166 |
| AstraZeneca(2 entities) | 3 | $158 |
| Regeneron Healthcare Solutions, Inc. | 6 | $146 |
| Axogen | 1 | $127 |
| Elucent Medical | 4 | $112 |
| Bioventus LLC | 2 | $106 |
| Olympus America Inc. | 1 | $67 |
| CSL Behring | 2 | $47 |
| Hologic Sales And Service, LLC | 2 | $40 |
| Organogenesis Inc. | 2 | $35 |
| Pacira Pharmaceuticals Incorporated | 1 | $25 |
| Covidien LP | 1 | $25 |
| Heron Therapeutics, Inc. | 1 | $24 |
| Sanara Medtech Inc. | 1 | $23 |
| Biom'up SA | 1 | $20 |
| Bard Peripheral Vascular, Inc. | 1 | $19 |
| Smith+Nephew | 1 | $18 |
| Kerecis Limited | 1 | $17 |
| Misonix Inc | 1 | $17 |
| Johnson & Johnson | 1 | $15 |
| Focal Therapeutics, Inc. | 1 | $14 |
| Conmed Corporation | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- 1688$819
- Da Vinci Surgical System$526
- EIKON$518
- 1788$350
- SPY-PHI SYSTEM$292
- ANDEXXA$125
How this compares
$4,479 in reported general payments places this provider in the 65th percentile of 43 surgical oncology providers in Georgia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Megestrol Acetate | 14 | $525 |
| Enoxaparin Sodium | 11 | $514 |
| Cephalexin | 69 | $281 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 59 | $181 |
| Levothyroxine Sodium | 16 | $137 |
| Neomycin Sulfate | 21 | $98 |
| Tramadol Hcl | 65 | $80 |
| Ciprofloxacin Hcl | 11 | $48 |
| Metronidazole | 22 | $38 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 12 | $37 |
Paid to pharmacies, not to this prescriber.
Other surgical oncology in Albany
- Eddie AbdallaAtlanta$34K
- Atuhani BurnettAtlanta$23K
- Anita JohnsonWoodstock$18K
- Danny YakoubAugusta$17K
- Nicole KounalakisAtlanta$14K
- Sartaj SangheraMarietta$10K
- Barry RosemanAtlanta$10K
- Arnold ConfortiMacon$9K
- James GarberSavannah$7K
- James GriffinAthens$7K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.